{
    "Trade/Device Name(s)": [
        "BD Veritor System for Rapid Detection of Flu A + B CLIA waived Kit",
        "BD Veritor System",
        "BD Veritor System Flu A + B"
    ],
    "Submitter Information": "BD Diagnostic Systems, Point of Care",
    "510(k) Number": "K160161",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112277",
        "K132259",
        "K132692",
        "K151291",
        "K152870"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "January 22, 2016",
    "Summary Letter Received Date": "January 27, 2016",
    "Submission Date": "January 22, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Veritor System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Antigen detection",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reader",
        "Test device",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit, an immunochromatographic assay for influenza A/B antigen detection.",
    "Indications for Use Summary": "Aid in diagnosis of influenza A and B viral infections by qualitative detection of their nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients; negative tests are presumptive and not intended to detect influenza C antigens.",
    "fda_folder": "Microbiology"
}